AcuCort AB Logo

AcuCort AB

Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.

ACUC | SPGR

Overview

Corporate Details

ISIN(s):
SE0009695927
LEI:
54930087FR3VVW5SU676
Country:
Sweden
Address:
Scheeletorget 1, 223 81 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

AcuCort AB is an innovative pharmaceutical company that develops and commercializes 'smart drugs'—improved, user-friendly treatments based on well-documented substances. The company's lead product is Zeqmelit®, a patented, rapidly dissolving oral film containing the cortisone dexamethasone. This novel dosage form is designed for the rapid and simple treatment of severe and acute allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting. AcuCort's strategy focuses on enhancing patient convenience and addressing unmet medical needs through improved drug delivery. The company commercializes its products through a global network of licensees and distribution partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AcuCort AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AcuCort AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AcuCort AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-24 Ebba Cecilia Fåhraeus Other Buy 91,000 81,900.00 SEK

Peer Companies

Company Country Ticker View
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea 086820
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden BIOVIC

Talk to a Data Expert

Have a question? We'll get back to you promptly.